Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PRAX
PRAX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PRAX News
Praxis Precision Medicines FDA Accepts New Drug Application for Ulixacaltamide
6d ago
seekingalpha
Praxis Precision Medicines' NDA for Ulixacaltamide Accepted by FDA
6d ago
NASDAQ.COM
Praxis Receives FDA Review Acceptance for Ulixacaltamide NDA
6d ago
Newsfilter
PRAXIS PRECISION MEDICINES INC: RAYMOND JAMES BEGINS COVERAGE WITH A STRONG BUY RATING AND A TARGET PRICE OF $815
Apr 10 2026
moomoo
Praxis Precision Medicines Reports Promising Drug Results
Apr 06 2026
seekingalpha
Praxis Receives FDA Priority Review for Relutrigine
Mar 30 2026
Newsfilter
5AM Venture Management Sells Entire Stake in Praxis Precision Medicines
Mar 18 2026
Fool
Cormorant Asset Management Sells Shares of Praxis Precision Medicines
Mar 16 2026
Fool
Cormorant Asset Management Reduces PRAX Holdings
Mar 16 2026
NASDAQ.COM
Deerfield Management Increases Stake in Praxis Precision Medicines
Mar 13 2026
Fool
Deerfield Management Increases PRAX Stake by 62,500 Shares
Mar 13 2026
NASDAQ.COM
Driehaus Capital Increases Stake in Praxis Precision Medicines
Mar 13 2026
Fool
Driehaus Capital Increases PRAX Holdings Significantly
Mar 13 2026
NASDAQ.COM
Xenon Pharmaceuticals Reports Positive Phase 3 X-TOLE2 Study Results
Mar 09 2026
Benzinga
Praxis Grants Restricted Stock Units to New Employees
Mar 04 2026
Yahoo Finance
Baker Bros. Increases Praxis Stake to 1.94% with $81.38M Purchase
Feb 23 2026
Fool
Show More News
